Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001685616-16-000001
Filing Date
2016-09-27
Accepted
2016-09-27 10:05:04
Documents
1
Effectiveness Date
2016-09-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4763
  Complete submission text file 0001685616-16-000001.txt   5811
Mailing Address 202 LENOX AVENUE UNIT #1 NEW YORK NY 10027
Business Address 202 LENOX AVENUE UNIT #1 NEW YORK NY 10027 646-454-1384
Oxygen Therapy, Inc. (Filer) CIK: 0001685616 (see all company filings)

EIN.: 812723728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-271332 | Film No.: 161903499